Head-To-Head Analysis: NeueHealth (NEUE) vs. Its Rivals

NeueHealth (NYSE:NEUE) is one of 3 publicly-traded companies in the “Healthcare Plans” industry, but how does it contrast to its peers? We will compare NeueHealth to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, dividends, valuation, earnings and risk.

Earnings and Valuation

This table compares NeueHealth and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$65.48 billion	$1.34 billion	-0.59

NeueHealth’s peers have higher revenue and earnings than NeueHealth. NeueHealth is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 75.4% of shares of all “Healthcare Plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Comparatively, 32.5% of shares of all “Healthcare Plans” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility and Risk

NeueHealth has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s peers have a beta of 0.53, indicating that their average stock price is 47% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for NeueHealth and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	3	105	337	18	2.80

NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 30.08%. As a group, “Healthcare Plans” companies have a potential upside of 2.68%. Given NeueHealth’s higher probable upside, equities research analysts clearly believe NeueHealth is more favorable than its peers.

Profitability

This table compares NeueHealth and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	0.19%	5.05%	2.04%

Summary

NeueHealth peers beat NeueHealth on 9 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.